Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
Antibody responses are critical for protection from developing severe COVID-19 following SARS-CoV-2 infection. Here the authors show that antibody responses against SARS-CoV-2 spike protein correlate with neutralizing capacity and protection, are not affected by heterologous boosting of influenza or...
Guardado en:
Autores principales: | Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, Monica Tolazzi, Martina Borghi, Cristina Brigatti, Maria Laura De Angelis, Marco Baratella, Elena Bazzigaluppi, Giulietta Venturi, Francesca Sironi, Andrea Canitano, Ilaria Marzinotto, Cristina Tresoldi, Fabio Ciceri, Lorenzo Piemonti, Donatella Negri, Andrea Cara, Vito Lampasona, Gabriella Scarlatti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d80ed3f91a004c7c8f240e8633323310 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis
por: Alexander Lind, et al.
Publicado: (2021) -
Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis
por: Ilaria Marzinotto, et al.
Publicado: (2021) -
Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Roberto Canitano, et al.
Publicado: (2008) -
Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research
por: Roberto Canitano, et al.
Publicado: (2021) -
Platform Work: From Digital Promises to Labor Challenges
por: Davide Arcidiacono, et al.
Publicado: (2019)